IUSZ:F:F-iShares Public Limited Company - iShares Core FTSE 100 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 9.453

Change

-0.01 (-0.05)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.27 (+1.02%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.43 (+0.87%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.14 (+0.93%)

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

+0.66 (+0.66%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.06 (+0.06%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.55 (+1.09%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.89B
0ZC:F Zscaler Inc

+4.26 (+2.56%)

USD 37.92B

ETFs Containing IUSZ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.32% 57% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.32% 57% F 63% D
Trailing 12 Months  
Capital Gain 13.30% 49% F 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.30% 49% F 58% F
Trailing 5 Years  
Capital Gain 11.20% 43% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.20% 43% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 6.86% 61% D- 61% D-
Dividend Return 6.86% 59% D- 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.86% 57% F 85% B
Risk Adjusted Return 57.81% 66% D+ 73% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike